Publications by authors named "V Parrak"

Claim this Profile
P
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.
Branislav Kovacech, Nicholas C Cullen, Petr Novak, Jozef Hanes, Eva Kontsekova, Vojtech Parrak

Alzheimers Res Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment.
Ivana Gerhardtova, Ivana Cizmarova, Timotej Jankech, Dominika Olesova, Josef Jampilek, Vojtech Parrak

Pharmaceuticals (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple and green capillary electrophoresis-mass spectrometry method for therapeutic drug monitoring of colistin in clinical plasma samples.
Ivana Cizmarova, Vojtech Parrak, Peter Secnik, Peter Secnik, Ladislav Sopko

Heliyon· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
Juraj Piestansky, Ivana Cizmarova, Peter Mikus, Vojtech Parrak, Pavel Babiak

Ther Drug Monit· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.
Branislav Kovacech, Lubica Fialova, Peter Filipcik, Rostislav Skrabana, Monika Zilkova, Vojtech Parrak

EBioMedicine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis